I B Bayer-Garner - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

I B Bayer-Garner

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The American Journal of Dermatopathology|April 19, 2000

Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinomaI B Bayer-Garner, B Dilday, R D Sanderson, et al.

Journal of Cutaneous Pathology|August 28, 2004

Carcinoma with thymus-like differentiation arising in the dermis of the head and neckI B Bayer-Garner, M E Kozovska, M R Schwartz, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 13, 2001

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regionsI B Bayer-Garner, R D Sanderson, M V Dhodapkar, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The American Journal of Dermatopathology|April 19, 2000

Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinomaI B Bayer-Garner, B Dilday, R D Sanderson, et al.

Journal of Cutaneous Pathology|August 28, 2004

Carcinoma with thymus-like differentiation arising in the dermis of the head and neckI B Bayer-Garner, M E Kozovska, M R Schwartz, et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 13, 2001

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regionsI B Bayer-Garner, R D Sanderson, M V Dhodapkar, et al.

Pageof 2